The Quality Incentive Program and Patient-Centered Dialysis Care: Mastering the Numbers.

Area of Science:

• Health Services Research
• Public Health Policy
• Nephrology Quality Improvement

Background:

• The End-Stage Renal Disease Quality Incentive Program (QIP) was mandated by the Medicare Improvement for Patients and Providers Act of 2008.
• Established in 2012, the QIP is the Centers for Medicare and Medicaid Services' (CMS) first value-based purchasing program.
• It links a portion of Medicare reimbursement for dialysis facilities to their performance on quality metrics.

Purpose of the Study:

• To critically appraise the End-Stage Renal Disease Quality Incentive Program (QIP) using the Quintuple Aim framework.
• To evaluate the successes and shortcomings of the QIP in improving dialysis care quality and patient outcomes.
• To provide recommendations for enhancing future iterations of the QIP.

Main Methods:

• A comprehensive review of the End-Stage Renal Disease Quality Incentive Program (QIP) implementation and evolution.
• Application of the Quintuple Aim framework (patient experience, population health, cost reduction, care coordination, and clinician and caregiver well-being) to assess the QIP.
• Analysis of QIP's effectiveness in identifying low-performing dialysis facilities and impacting patient outcomes.

Main Results:

• The QIP has successfully identified dialysis facilities with lower performance based on defined quality metrics.
• The program's impact on improving overall patient outcomes in dialysis, particularly for those facing significant health-related social needs, remains limited.
• The QIP's focus has evolved from managing underutilization to aligning with broader CMS health objectives.

Conclusions:

• The End-Stage Renal Disease Quality Incentive Program (QIP) has merits in performance identification but requires refinement to demonstrably improve patient outcomes.
• Addressing health-related social needs is crucial for the QIP to achieve equitable improvements in dialysis care.
• Future QIP iterations should incorporate strategies to better support vulnerable patient populations and enhance overall health equity.